£112.80

This is the most expensive it has ever been. Walk away.

£113 today · previous high £113 · all-time low £103

Springer Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 75 days · 75 data points (no recent data)

Historical
Generating forecast…
£112.80 £102.28 £104.58 £106.87 £109.17 £111.46 £113.76 25 July 2026 12 August 2026 31 August 2026 18 September 2026 07 October 2026
View at Amazon ↗

Price data last checked 16 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 75 days • 2 price levels

Days at Price
Current Price
74 days 1 day · current 0 19 37 56 74 £103 £113 Days at Price

Price Analysis

Most common price: £103 (74 days, 98.7%)

Price range: £103 - £113

Price levels: 2 different prices over 75 days

Description

This comprehensive medical reference from Springer examines minimal residual disease and circulating tumour cells in breast cancer patients, offering clinicians and researchers up-to-date insights into metastatic progression. The book details how studying circulating and disseminated tumour cells (CTCs/DTCs) enhances understanding of breast cancer metastasis mechanisms. It systematically reviews detection technologies and characterisation methods for CTCs and DTCs, evaluating their clinical merits and limitations. Detailed chapters explore the clinical relevance of tumour cell detection and its application in patient management and prognosis. Part of the Recent Results in Cancer Research series volume 195, this text bridges laboratory science and clinical practice for oncologists, pathologists, and cancer researchers seeking evidence-based approaches to minimal residual disease assessment.

Key Features

Springer publication provides authoritative coverage of minimal residual disease assessment in breast cancer diagnosis and monitoring.

Comprehensive review of circulating and disseminated tumour cell detection technologies, including their clinical applications and limitations.

Volume 195 in the Recent Results in Cancer Research series delivers current evidence on CTCs and DTCs in metastatic disease progression.

Detailed exploration of how minimal residual disease and tumour cell detection inform patient prognosis and treatment decisions.

Clinically focused chapters bridge laboratory methodology and practical oncology application for healthcare practitioners.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
23 April 2012
Listed Since
13 January 2012

Barcode

No barcode data available

Similar Products You Might Like

Cell and Molecular Biology of Breast Cancer
97% match

Cell and Molecular Biology of Breast Cancer

Humana

£112.53 26 Sep 2026
Breast Cancer: Prognosis, Treatment, and Prevention
97% match

Breast Cancer: Prognosis, Treatment, and Prevention

CRC Press

£150.00 06 Oct 2026
Breast Cancer: Molecular Genetics, Pathogenesis, Therapeutics
97% match

Breast Cancer: Molecular Genetics, Pathogenesis, Therapeutics

Humana

£179.99 11 Oct 2026
Mammary Tumor Cell Cycle, Differentiation, and Metastasis: Advances in Cellular and Molecular Biology of Breast Cancer: 83 (Cancer Treatment and Research, 83)
97% match

Mammary Tumor Cell Cycle, Differentiation, and Metastasis: Advances in Cellular and Molecular Biology of Breast Cancer: 83 (Cancer Treatment and Research, 83)

Springer

£212.37 16 Aug 2026
Mammary Tumorigenesis and Malignant Progression: Advances in Cellular and Molecular Biology of Breast Cancer: 71 (Cancer Treatment and Research, 71)
97% match

Mammary Tumorigenesis and Malignant Progression: Advances in Cellular and Molecular Biology of Breast Cancer: 71 (Cancer Treatment and Research, 71)

Springer

£149.53 15 Aug 2026
Mammary Tumor Cell Cycle, Differentiation, and Metastasis: Advances in Cellular and Molecular Biology of Breast Cancer: 83 (Cancer Treatment and Research, 83)
97% match

Mammary Tumor Cell Cycle, Differentiation, and Metastasis: Advances in Cellular and Molecular Biology of Breast Cancer: 83 (Cancer Treatment and Research, 83)

Springer

£224.73 23 Aug 2026
Breast Cancer: Prognosis, Treatment, and Prevention
97% match

Breast Cancer: Prognosis, Treatment, and Prevention

CRC Press

£41.99 05 Oct 2026
Breast Cancer Management and Molecular Medicine
97% match

Breast Cancer Management and Molecular Medicine

Springer

£156.70 18 Aug 2026
A Guide to Breast Cancer Research: From Cellular Heterogeneity and Molecular Mechanisms to Therapy: 1464 (Advances in Experimental Medicine and Biology, 1464)
97% match

A Guide to Breast Cancer Research: From Cellular Heterogeneity and Molecular Mechanisms to Therapy: 1464 (Advances in Experimental Medicine and Biology, 1464)

Springer

£80.98 12 Oct 2026
Breast Cancer: Translational Therapeutic Strategies: 2 (Translational Medicine)
97% match

Breast Cancer: Translational Therapeutic Strategies: 2 (Translational Medicine)

CRC Press

£125.00 17 Sep 2026
Medical Therapy of Breast Cancer
97% match

Medical Therapy of Breast Cancer

Cambridge University Press

£81.88 12 Sep 2026
Early Breast Cancer: From Screening to Multidisciplinary Management, Third Edition
97% match

Early Breast Cancer: From Screening to Multidisciplinary Management, Third Edition

CRC Press

£125.80 16 Aug 2026
Early Breast Cancer: From Screening to Multidisciplinary Management, Third Edition
97% match

Early Breast Cancer: From Screening to Multidisciplinary Management, Third Edition

CRC Press

£68.99 30 Sep 2026
Translational Research in Breast Cancer: 1187 (Advances in Experimental Medicine and Biology, 1187)
97% match

Translational Research in Breast Cancer: 1187 (Advances in Experimental Medicine and Biology, 1187)

Springer

£159.99 01 Oct 2026
Metastasis of Breast Cancer: 11 (Cancer Metastasis - Biology and Treatment, 11)
97% match

Metastasis of Breast Cancer: 11 (Cancer Metastasis - Biology and Treatment, 11)

Springer

£82.69 16 Aug 2026
Approaches to Understanding Breast Cancer (Volume 151) (Progress in Molecular Biology and Translational Science, Volume 151)
97% match

Approaches to Understanding Breast Cancer (Volume 151) (Progress in Molecular Biology and Translational Science, Volume 151)

Elsevier

£118.99 14 Oct 2026
Oncologic Breast Surgery - Updates in Surgery Medical Reference
97% match

Oncologic Breast Surgery - Updates in Surgery Medical Reference

Springer

£131.16 07 Oct 2026
Biomarkers in Breast Cancer (Cancer Drug Discovery and Development)
97% match

Biomarkers in Breast Cancer (Cancer Drug Discovery and Development)

Humana

£144.99 19 Aug 2026
Breast Diseases: Guidelines for Management
97% match

Breast Diseases: Guidelines for Management

CRC Press

£119.35 14 Aug 2026
Breast Diseases: Guidelines for Management
97% match

Breast Diseases: Guidelines for Management

CRC Press

£60.40 13 Aug 2026
Metastasis of Breast Cancer: v. 11 (Cancer Metastasis - Biology and Treatment)
97% match

Metastasis of Breast Cancer: v. 11 (Cancer Metastasis - Biology and Treatment)

Springer

£45.19 11 Sep 2026
Breast Cancer, a Heterogeneous Disease Entity: The Very Early Stages
97% match

Breast Cancer, a Heterogeneous Disease Entity: The Very Early Stages

Springer

£147.14 22 Aug 2026
Breast Cancer: Tumor Microenvironment and Biology
97% match

Breast Cancer: Tumor Microenvironment and Biology

Hayle Medical

£63.15 17 Sep 2026
Breast Cancer Facts, Myths, and Controversies: Understanding Current Screenings and Treatments (Public Healthissues and Developments)
97% match

Breast Cancer Facts, Myths, and Controversies: Understanding Current Screenings and Treatments (Public Healthissues and Developments)

Bloomsbury

£45.17 30 Sep 2026